A Study to Evaluate the Safety of GSK2398852 When Co-administered With GSK2315698 in Patients With Systemic Amyloidosis
Clinical trial NCT01777243 · COMPLETED
Trial details
- NCT number
- NCT01777243
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-13
- Primary completion
- 2015-12-22
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.